EORTC protocol 24982

Phase II study on Gemcitabine in Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Trial StatusAll trial activities ended
DatesDate of activation: 02-Apr-01
Closed on : 25-Apr-03
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size29
Number of steps1
DrugGemcitabine
Study StaffJan Bogaerts (Statistician) - EORTC Headquarters, Brussels
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00017498
EudraCT
Back to Protocol section